↓ Skip to main content

Thioridazine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
156 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thioridazine for schizophrenia
Published in
Cochrane database of systematic reviews, July 2007
DOI 10.1002/14651858.cd001944.pub2
Pubmed ID
Authors

Mark Fenton, John Rathbone, Joe Reilly

Abstract

Thioridazine is an antipsychotic that can still be used for schizophrenia although it is associated with the cardiac arrhythmia, torsades de pointe.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 1%
South Africa 1 <1%
Unknown 153 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 18%
Student > Bachelor 22 14%
Researcher 18 12%
Student > Ph. D. Student 15 10%
Student > Doctoral Student 13 8%
Other 31 20%
Unknown 29 19%
Readers by discipline Count As %
Medicine and Dentistry 60 38%
Psychology 21 13%
Nursing and Health Professions 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 4%
Neuroscience 5 3%
Other 19 12%
Unknown 33 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2017.
All research outputs
#3,053,265
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#5,150
of 8,923 outputs
Outputs of similar age
#63,338
of 287,431 outputs
Outputs of similar age from Cochrane database of systematic reviews
#158
of 228 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,431 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.